Neurocrine Biosciences (NBIX) Market Cap (1999 - 2026)
Neurocrine Biosciences (NBIX) market cap from Nov 1, 1999 to Jun 3, 2026. The current Neurocrine Biosciences (NBIX) market cap is $17B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Market Cap
Neurocrine Biosciences (NBIX) Market Cap CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +8.91% |
| 3 Years TTM | +10.86% |
| 5 Years TTM | +6.87% |
| 10 Years TTM | +13.10% |
| All Time TTM | +6.21% |
Annual Market Cap change of Neurocrine Biosciences (NBIX)
| Year | Market Cap | Change |
|---|---|---|
| 2026 | $17B | +17.00% |
| 2025 | $14B | +4.64% |
| 2024 | $14B | +4.86% |
| 2023 | $13B | +12.73% |
| 2022 | $11B | +42.01% |
| 2021 | $8.08B | -9.81% |
| 2020 | $8.96B | -9.67% |
| 2019 | $9.92B | +53.02% |
| 2018 | $6.48B | -5.54% |
| 2017 | $6.86B | +104.17% |
| 2016 | $3.36B | -31.11% |
| 2015 | $4.88B | +185.67% |
| 2014 | $1.71B | +171.56% |
| 2013 | $629M | +26.57% |
| 2012 | $497M | +5.83% |
| 2011 | $470M | +12.01% |
| 2010 | $419M | +293.88% |
| 2009 | $106M | -66.93% |
| 2008 | $322M | -29.52% |
| 2007 | $457M | -56.43% |
| 2006 | $1.05B | -83.39% |
| 2005 | $6.31B | +27.24% |
| 2004 | $4.96B | -9.61% |
| 2003 | $5.49B | +19.45% |
| 2002 | $4.59B | -11.01% |
| 2001 | $5.16B | +54.87% |
| 2000 | $3.33B | +33.86% |
| 1999 | $2.49B | N/A |
Comparison Neurocrine Biosciences (NBIX) market cap with competitors
Neurocrine Biosciences (NBIX) market cap is $16.61B.